Suite 1300
Salt Lake City, UT 84111
Block-1 3rd Floor, Perungudi Bypass Rd, Perungudi,
Chennai - 600096
MGR Main Rd,
Perungudi, Chennai - 600096
Villupuram,
Tamil Nadu – 605602
MAC Pricing Appeals
MAC Pricing Appeals That Recover the Margin Below-Cost Reimbursement Quietly Drains
Maximum Allowable Cost (MAC) pricing appeals across PBM and Medicaid programs — with below-cost claim identification, invoice documentation, MAC appeal submission, and the recovery infrastructure LTC pharmacy operations need when generic reimbursement consistently runs below acquisition cost.
72%+
MAC Appeal Success Rate
30–50%
Recovery of Underpaid Claims
<10 DAYS
Appeal Resolution Time
The Reality
Why MAC pricing has become the single biggest generic drug margin threat to LTC pharmacy?
Maximum Allowable Cost (MAC) pricing is the methodology PBMs and state Medicaid programs use to set generic drug reimbursement — typically a price tied to a basket of wholesale acquisition cost data points. When MAC prices fall below actual pharmacy acquisition cost (because of generic shortages, manufacturer pricing changes, or stale MAC list maintenance), pharmacies dispense generic drugs at a loss. For LTC pharmacies dispensing high generic volumes across hundreds of NDCs, the cumulative below-cost dispensing exposure runs into hundreds of thousands or millions of dollars annually. Most LTC pharmacies absorb these losses because MAC appeal infrastructure isn’t operationally established.
Below-Cost Dispensing Volume
Generic drug shortages, manufacturer pricing changes, and stale MAC list maintenance create persistent gaps between MAC reimbursement and pharmacy acquisition cost. LTC pharmacies dispensing high generic volumes across diverse NDCs face below-cost dispensing on a meaningful percentage of claims at any given time.
State MAC Appeal Process Variability
Each state Medicaid program operates its own MAC appeal process — different filing requirements, different documentation standards, different timelines, different overturn rates. Multi-state LTC pharmacies face 6–15 different state MAC appeal systems simultaneously.
PBM MAC Appeal Process Variability
Each PBM operates its own MAC appeal process — Express Scripts, CVS Caremark, OptumRx, Humana Pharmacy Solutions, Prime Therapeutics, and other PBMs each have distinct appeal protocols. Generic MAC appeal workflow can't navigate PBM-specific submission requirements.
Invoice Documentation Burden
Successful MAC appeals require invoice documentation proving actual acquisition cost above MAC reimbursement. Documentation must be specific to dispensing date, NDC, and acquisition source. Most LTC pharmacy operations don't maintain invoice documentation infrastructure ready for MAC appeal submission.
MAC Update Cycle Lag
PBM and Medicaid MAC lists update on cycles ranging from daily to monthly. Acquisition cost changes happen continuously. The lag between actual cost shifts and MAC list updates creates predictable windows of below-cost dispensing — windows that are invisible without dedicated monitoring infrastructure.
Recovery Window Pressure
MAC appeals operate on short filing windows — typically 14-60 days from claim adjudication depending on PBM or state program. Missed windows close the appeal pathway permanently, and aged below-cost claims become permanent loss.
Our approach
We run MAC pricing appeals as standing below-cost recovery operation
AnnexMed runs MAC pricing appeals as dedicated recovery operation — with below-cost claim identification across PBM and Medicaid programs, invoice documentation infrastructure, PBM-specific and state-specific appeal protocols, MAC update cycle monitoring, and filing window discipline. Below-cost dispensing stops being absorbed as cost-of-doing-business and becomes systematically recovered margin.
We serve LTC pharmacies, closed-door pharmacies, and institutional pharmacies dispensing high generic volumes where MAC pricing pressure threatens generic margin. Our team manages MAC appeals across major PBMs — Express Scripts, CVS Caremark, OptumRx, Humana Pharmacy Solutions, Prime Therapeutics, Magellan Pharmacy Solutions — and all 50 state Medicaid MAC appeal programs with PBM-specific and state-specific appeal protocols.
Recent client results
A regional LTC pharmacy serving 3,200 residents across 48 facilities identified $1.2M in annual below-cost generic dispensing exposure within 90 days of go-live, recovering an estimated $720K through systematic MAC appeal filing within the first year. A multi-state LTC pharmacy operating across 7 states improved MAC appeal overturn rate from 41% to 74% through PBM-specific and state-specific appeal protocols replacing generic appeal templates. A specialty LTC pharmacy dispensing substantial atypical antipsychotic generic volume recovered $380K in annual below-cost atypical dispensing through dedicated invoice documentation infrastructure and active MAC appeal workflow.
72%+
MAC Appeal Overturn Rate
All 50
State Medicaid MAC Programs
All Major
PBM MAC Appeal Coverage
How we support you
End-to-end MAC pricing appeal operation
AnnexMed runs MAC pricing appeals as a three-stage operation — below-cost claim identification with MAC update cycle monitoring, invoice documentation collection and assembly, and PBM-specific and state-specific appeal submission with overturn tracking — so below-cost dispensing exposure gets surfaced, documented, and recovered systematically.
Below-Cost Identification
MAC vs. acquisition cost monitoring
- Real-time MAC vs. acquisition cost comparison
- NDC-level below-cost claim flagging
- Aggregate exposure trending by NDC and PBM
- MAC update cycle monitoring across PBMs
- State Medicaid MAC list monitoring
- Filing window calculation per appeal pathway
Invoice Documentation
Appeal-ready documentation
- Wholesale invoice collection by NDC and date
- Acquisition cost documentation per dispensing event
- Multi-source acquisition price reconciliation
- Invoice archive infrastructure for appeal submission
- Documentation completeness validation
- 5+ year invoice archive retention
Appeal Submission
PBM and state-specific protocols
- Express Scripts, CVS Caremark, OptumRx appeal protocols
- Humana, Prime Therapeutics, Magellan Pharmacy Solutions
- All 50 state Medicaid MAC appeal programs
- Filing window discipline per pathway
- Overturn tracking and recovery confirmation
- Aged below-cost claim historical sweep
Financial impact
What active MAC appeal operations mean in dollars?
For an LTC pharmacy dispensing substantial generic volume across PBM and Medicaid coverage, dedicated MAC pricing appeal operations regularly deliver $400K–$1.8M+ in net annual financial benefit through below-cost dispensing recovery, aged claim sweep, invoice documentation infrastructure, and generic margin protection. Most LTC pharmacies achieve full ROI on MAC appeal operations within 4–6 months — often faster when significant aged below-cost exposure is recoverable.
Fast Results
Below-cost claim identification begins from the first month of go-live as real-time MAC vs. acquisition cost monitoring activates. MAC appeal recovery typically pays back inside 90 days through systematic appeal filing on accumulated below-cost claims.
Built for Multi-PBM, Multi-State Reality
MAC appeal infrastructure supports all major PBMs and all 50 state Medicaid MAC programs simultaneously. Multi-state LTC pharmacies don’t face vendor coverage gaps that leave below-cost dispensing exposure unrecovered.
Improvement Area
Estimated Annual Impact
Active MAC Appeal Recovery (72% overturn)
$400K – $1.4M annually in below-cost claim recovery
Aged Below-Cost Claim Historical Sweep (first 6 months)
$200K – $800K in one-time historical recovery
MAC Update Cycle Monitoring
$100K – $400K annually in early exposure identification
Invoice Documentation Infrastructure
$80K – $300K annually in appeal readiness value
Multi-PBM Coordination
$150K – $500K annually across PBM-specific protocols
State Medicaid MAC Coverage
$100K – $400K annually for multi-state operations
Staffing Cost Reduction / Replacement
$120K – $300K annually
MAC pricing appeal performance targets
Performance Metric
Industry Benchmark
AnnexMed Target
MAC Appeal Overturn Rate
Industry avg: 38–52%
72%+
Below-Cost Claim Identification
Industry standard: Quarterly retrospective
Real-time
Filing Window Capture Rate
Industry avg: 62–74%
98%+
PBM Coverage
Most operations cover 1–2 PBMs
All major PBMs
State Medicaid Coverage
Most vendors cover 5–10 states
All 50 states
Invoice Documentation Readiness
Industry: documentation gathered reactively
Appeal-ready archive
Aged Below-Cost Recovery
Industry: rarely pursued
Six-month historical sweep standard
MAC Update Monitoring
Industry standard: Monthly review
Real-time across PBMs and Medicaid
Why Annexmed?
Passive absorption vs. AnnexMed active MAC recovery
MAC pricing appeals is where generic drug margin gets recovered or quietly absorbed as below-cost dispensing loss. Here’s how AnnexMed compares to typical in-house or generalist LTC pharmacy operations:
In-House / Traditional
AnnexMed Partnership
Recovery Approach
Passive; below-cost dispensing absorbed
Active recovery operation with systematic appeal filing
Below-Cost Identification
Quarterly retrospective if at all
Real-time MAC vs. acquisition cost monitoring
Appeal Overturn Rate
38–52% on filed appeals
72%+ with PBM-specific and state-specific protocols
PBM Coverage
Top 1–2 PBMs at best
All major PBMs with PBM-specific appeal protocols
State Medicaid Coverage
Strong on 1–2 home states
All 50 state Medicaid MAC appeal programs
Invoice Documentation
Gathered reactively under appeal pressure
Appeal-ready archive infrastructure maintained continuously
Aged Below-Cost Treatment
Aged claims past appeal window absorbed
Six-month historical sweep with systematic recovery
Cost to Operate
$60K–$85K per FTE for MAC appeal specialist
30-40% lower with no hiring, attrition, or training overhead
Technology
Powered by proprietary AI & analytics
AnnexMed’s technology stack was built for payer-specific operational demands, not adapted from provider-side billing tools. Risk adjustment accuracy, payment integrity, and credentialing compliance each require different data models, workflow logic, and reporting architectures than provider RCM. Our platform reflects that.
AI Agents & Automation
AI Agents & Intelligent Automation deploys autonomous AI agents across the full revenue cycle, automating eligibility verification, prior authorization, claims processing, payment posting, and denial management at hospital scale and speed.
Data & Analytics Platform
Data & Analytics Platform delivers real-time Power BI dashboards built for hospital executive visibility, including system-wide KPIs, service line performance, payer analysis, productivity, financial forecasting, and national benchmarking insights.
Intelligent AR Management
Intelligent AR Management handles A/R follow-up at hospital scale with intelligent worklists prioritized by dollar value and aging, payer-specific follow-up rules, automated escalation for high-value accounts, and full accountability for every claim.
Computer Assisted Coding
Computer Assisted Coding orchestrates hospital coding operation, intelligent chart assignment by service line, TAT tracking with SLA monitoring, quality audits with accuracy scoring, and coder performance management at enterprise scale.
Together, these platforms create a fully instrumented RCM operation where nothing falls through the cracks. You don’t interact with these systems directly, but the results they enable show up directly in your financial performance.
Ready to stop absorbing below-cost dispensing as cost-of-doing-business?
Most LTC pharmacies identify $400K–$1.5M in below-cost dispensing recovery and aged MAC appeal opportunity in their first assessment. Schedule a no-obligation MAC Pricing Audit.
Trusted by 100+ Healthcare Providers | AAPC, AHIMA & AAHAM Certified | SOC 2 Type II | HIPAA Compliant
Payer client outcomes
$15M–$40M
Risk
Adjustment
$18M–$50M
Payment
Integrity
6 Weeks
Credentialing Clearance
$15M–$50M+
Revenue
Impact
Case Studies
See the impact we deliver
Discover how AnnexMed reduces denials, accelerates reimbursements, and strengthens financial performance. Backed by measurable outcomes and proven RCM expertise, we deliver operational excellence, revenue stability, and sustainable growth you can trust.
Client Voices
See how our clients succeed
Proven RCM expertise. Delivered at scale.
For over 20 years, AnnexMed has delivered RCM solutions nationwide, combining expert billing, coding, and AR support to drive measurable results and growth.
- 20+ years of proven healthcare RCM experience
- 1,500+ professionals supporting billing, coding & AR
- 500+ certified coders across multiple specialties
- 99%+ compliance with HIPAA and security standards
- All 50 states served with consistent, scalable operations
